Department of Medicine, McMaster University, Hamilton, ON, Canada.
Hematol Oncol Clin North Am. 2010 Aug;24(4):677-82, vii. doi: 10.1016/j.hoc.2010.05.002.
Pulmonary embolism (PE) is the most dangerous complication of venous thrombosis. Objectively confirmed PE is a potentially life-threatening complication of critical illness. In medical-surgical critically ill patients, signs and symptoms are nonspecific, the clinical pretest probability may be low, and diagnostic tests may not be done or may yield ambiguous results. Therefore, PE is often undiagnosed and untreated; autopsy findings indicate that PE is common in intensive care unit (ICU) decedents. PE may delay weaning from mechanical ventilation, increase the length of stay in ICU and hospital, and increase the risk of death. More research is needed on PE in medical-surgical ICU patients including issues on the epidemiologic aspects of PE (including risk factors and attributable morbidity and mortality) and treatment of PE (including pharmacologic and nonpharmacologic approaches, determinants of treatment variation, and predictors of PE outcome adjusted for treatment).
肺栓塞(PE)是静脉血栓最危险的并发症。经客观证实的 PE 是危重病患者潜在的致命并发症。在外科重症监护病房(ICU)患者中,体征和症状无特异性,临床前期概率可能较低,诊断性检查可能未进行或结果可能不明确。因此,PE 常被漏诊和未治疗;尸检结果表明,PE 在 ICU 死亡者中很常见。PE 可延迟机械通气撤机,延长 ICU 和医院的住院时间,并增加死亡风险。需要对包括 PE 的流行病学方面(包括危险因素和可归因的发病率和死亡率)和 PE 的治疗(包括药物和非药物方法、治疗差异的决定因素以及调整治疗的 PE 结局预测因子)在内的外科 ICU 患者中的 PE 进行更多研究。